Given that FABP4 secreted by adipose tissue could serve as an adipokine, providing energy support and promoting oncogenic signaling activation in tumor cells [14, 17, 21], these findings provide further evidence that tumor cells could be taking up adipose tissue-derived FABP4 for their invasive benefits at the frontline. Here, FABP4 is linked to neoplasm.